Lariago Syrup 60 ml

Babies: The studies on the safety and efficacy of lariago syrup in babies/infants are limited. The studies state that lariago syrup may be safe to use in infants and children.
Please consult your doctor before taking this medicine. Lactating mothers: Not applicable. Pregnancy: Not applicable. Driving: Not applicable. Alcohol: Not applicable. Kidney: Lariago syrup is considered safe to use in children with kidney disease.
The dose adjustment may not be recommended. It is not recommended in children with severe kidney disease.
Please consult your doctor before using this medicine. Liver: Lariago syrup should be used with caution in children with liver disease.
The dose adjustment may be recommended. Seek a doctor’s advice before using this medicine..

Visual disturbances Itching Deafness Ringing in the ears Myopathy Nausea Vomiting Diarrhoea Loss of appetite Hepatitis Skin changes Anaemia Convulsions Decreased blood pressure .

The exact mechanism of lariago in the treatment of malaria is unknown. This medicine works by concentrating in the cells of the parasite and inhibits the enzyme responsible for the growth of the malarial parasite..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Lariago syrup is an antimalarial agent that is used in the treatment of malaria. • Give the medicine exactly as advised by the doctor. Do not miss the dose even if your child feels better. • Should use this medicine with caution in children with liver disease and eye diseases. • If your child experiences any undesirable effects, then seek the doctor’s advice.
• Monitor the blood counts regularly as lariago may cause anaemia. • Inform your doctor if your child has taken any vaccine within the past three months..

Contraindicated • Lariago + Artemether: Artemether increases the toxicity of lariago by qtc interval. • Lariago + Voriconazole: Lariago increases the toxicity of voriconazole by qtc interval. Serious • Lariago + Amiodarone: Lariago increases the toxicity of amiodarone by qtc interval. • Lariago + Procainamide: Lariago increases the toxicity of procainamide by qtc interval. Monitor closely • Lariago + Albuterol: Concurrent administration may result in increased qtc interval. • Lariago + Cholera vaccine: Lariago decreases the level or effect of the cholera vaccine by opposing its effect. Minor • Lariago + Formoterol: Lariago increases the toxicity of formoterol by qtc interval. • Lariago + Primaquine: Concurrent administration may increase the risk of hemolysis in g6pd deficient patients. .